These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36773379)

  • 1. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis.
    Kim C; Salvo G; Ishikawa M; Chen TC; Jhingran A; Bhosale P; Ramalingam P; Frumovitz M
    Gynecol Oncol; 2023 Mar; 170():328-332. PubMed ID: 36773379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
    BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment for neuroendocrine carcinoma of the uterine cervix.
    Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M
    Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
    Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
    Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
    Wang R; Xiao Y; Ma L; Wu Z; Xia H
    Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri.
    Alvarez RD; Gelder MS; Gore H; Soong SJ; Partridge EE
    Surg Gynecol Obstet; 1993 Jun; 176(6):539-42. PubMed ID: 8322125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
    Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of recurrence and survival in neuroendocrine cervical cancer.
    Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
    Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging and staging of neuroendocrine cervical cancer.
    Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P
    Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix.
    Goto S; Terao Y; Kamigaki T; Takimoto R; Naitoh K; Makita K; Yasumoto K; Okada S; Takizawa K; Yokomichi N; Suzuki N; Takeda S
    Anticancer Res; 2020 Aug; 40(8):4741-4748. PubMed ID: 32727800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
    Sert BM; Kristensen GB; Kleppe A; Dørum A
    Gynecol Oncol; 2021 Aug; 162(2):284-291. PubMed ID: 34083029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
    Casarin J; Buda A; Bogani G; Fanfani F; Papadia A; Ceccaroni M; Malzoni M; Pellegrino A; Ferrari F; Greggi S; Uccella S; Pinelli C; Cromi A; Ditto A; Di Martino G; Anchora LP; Falcone F; Bonfiglio F; Odicino F; Mueller M; Scambia G; Raspagliesi F; Landoni F; Ghezzi F
    Gynecol Oncol; 2020 Oct; 159(1):164-170. PubMed ID: 32665147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre Mdo R
    Sao Paulo Med J; 2007 Jul; 125(4):231-6. PubMed ID: 17992395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
    Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
    Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.